Bridging Finance kept investors in the dark about an emergency cash infusion and was given legal advice that the transaction did not require their consent
Esstra Industries Inc.: Esstra Industries Announces Appointment of New Director
Esstra Industries Inc. (
Exchange ), that Mr. Greg Kuenzel has been appointed to the Board of Directors.
Mr. Kuenzel is a Fellow of the Institute of Chartered Accountants in England & Wales with over 25 years of corporate and financial experience. He began his career providing audit and corporate services in Perth, Australia before moving to the UK in 2003. For the past 16 years, he has been working with London listed companies, predominantly within the mining and resources sectors. He has extensive experience in corporate finance, fundraising, investor relations and financial and management reporting. Mr. Kuenzel is Finance Director of Empire Metals Limited and a Partner at Westend Corporate LLP, a financial consulting firm based in London.
Pampa Metals Corp.: Pampa Metals Initiates Geophysical Survey at its Cerro Buenos Aires Copper & Precious Metals Project in Chile
(CSE:PM)(FSE:FIRA)(OTC PINK:PMMCF)
is pleased to provide an update on its exploration programs as well as announcing that the company has initiated a gradient array induced polarisation (IP) geophysical survey at its Cerro Buenos Aires copper and precious metals project in northern Chile.
Pampa Metals is pleased to be advancing its exploration program in a rapid and efficient manner since inception less than 6 months ago, with 3 projects already subject to detailed surface mapping and geophysical surveying, and 2 projects subject to a Letter Agreement with Austral Gold Ltd. that will allow for a rapid advance of their exploration. An additional project, Block 3, is currently undergoing detailed geological mapping, with results to be reported in due course. An initial drilling program is being planned for implementation around mid-June, with the highest
WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “
Company” or “
WPD”) a clinical-stage pharmaceutical company, is pleased to announce that it has been conditionally awarded a grant of $6,730,036 (20,394,049.68 PLN) from the Polish National Center for Research and Development (“
NCRD”), for the development of Annamycin, the Company’s drug candidate used in the treatment of Acute Myeloid Leukemia (“
AML”).
Annamycin is a “next generation” anthracycline, that has been shown to be less cardiotoxic compared to other anthracycline, such as doxorubicin, and to avoid multidrug resistance, so the use of Annamycin may not face the same dose limitations imposed on doxorubicin. The project entitled: “A novel approach to the therapy of acute myeloid leukemia (AML)” will be co-financed by the European Union, from the European Regional Development Fund, under the Smart Growth Operational Program 2014-2020. The funds will be used on the continued development of An
This article appears in the June 2021 issue of Advisor’s Edge
When the Canadian Securities Administrators decided to tackle activist short-selling late last year, it was already a thorny topic with the potential to cross over into debates about how information is shared online and even free speech.
Then came the GameStop saga. Retail investors’ surprising demonstration of might earlier this year inflicted huge losses on hedge funds shorting the brick-and-mortar video game retailer, pushing the company’s shares to improbable heights. Investors also showed they can organize online and respond to information in unpredictable ways that have disorienting effects on financial markets.